Founders Message: May 2, 2022

To Our Valued Shareholders, Supporters, Friends and Colleagues:

Big things are happening at Optimi. Thank you for being a part of them.

As we’ve kicked off our year of commercialization, we’ve experienced an incredible response from backers at every level. The knowledge that so many of you are excited to be investing in the scalable future of natural, accessible psilocybin and its implications for mental health is a powerful affirmation of everything we stand for.

On the ground, watching our facility take shape and seeing our first crop of GMP psilocybin grow, we’re conscious both of all that we’ve achieved so far and of how much we still have to accomplish.

Being a top tier ingredient supplier of pharmaceutical grade psilocybin and functional mushrooms is our number one goal. This is precisely why we have invested so heavily in our 10,000 square foot GMP-grade facility.

It’s simple: to be the best, we have to set the highest operational standards in the industry, bar none.

Why is growing natural, pharmaceutical grade psilocybin so important to our business and customers seeking our products?

First, as a company we believe that the only pathway to a regulated safe supply of psilocybin in Canada must come from a licensed, GMP facility. In fact, we were pleased to hear Health Canada make that important distinction in an industry meeting on March 24, 2022 when they were asked about quality of production and supply.

Second, properly sourced, pharmaceutical grade psilocybin is the only way to know for sure that you’re giving your body the highest, purest, and most bioavailable form of an ingredient possible. Our psilocybin and functional mushrooms are analyzed in our state-of-the-art laboratory and sent for third party analytical testing to ensure an extremely high standard of purity and maximum absorption.

And third, companies in emergent industries that take the time to get it right like Optimi has are rare. We believe this shows our commitment to safety, transparency and efficacy, which is why we are excited to announce that we’ll be opening the doors of our Princeton, British Columbia facility to the world on Friday, May 27th, 2022.

We’d like to invite all of you to join us. To RSVP, please email event organizer Michael Kydd at info@kyddergroup.com.

And that’s not all…

We know that success is impossible without community, so we’ll be welcoming the entire town of Princeton and residents from the surrounding area for this unique celebration.

This sector has the power to touch people’s lives not just as medicine, but as a natural and sustainable industry that can drive job creation for the Main Streets of North America. We’re proud of Princeton and tremendously grateful for the support we’ve received from this wonderful town. Now we’re eager to pay it forward.

Thank you.

JJ, Dane, Bryan, and Jacob

ABOUT OPTIMI

(CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN)

FOR INTERVIEW REQUESTS OR FURTHER INFORMATION PLEASE CONTACT:

Investor Relations
Email: investors@optimihealth.ca
Phone: +1 (902) 880 6121
Web: www.optimihealth.ca

FOR INTERVIEW REQUESTS OR FURTHER INFORMATION PLEASE CONTACT:

Investor Relations
Email: investors@optimihealth.ca
Phone: +1 (902) 880 6121
Web: www.optimihealth.ca

FORWARD‐LOOKING STATEMENTS

Products do not contain psilocybin

Search
Get news & updates directly to your inbox.
Interested In Optimi? Let's Talk.